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0022-2836 © 2008 Elsevier Ltd.Open acceActivation of the fibroblast growth factor receptor (FGFR) by neural cell
adhesion molecule (NCAM) is essential for NCAM-mediated neurite
outgrowth. Previous peptide studies have identified two regions in the
fibronectin type 3 (FN3)-like domains of NCAM as being important
for these activities. Here we report the crystal structure of the NCAM
FN3 domain tandem, which reveals an acutely bent domain arrangement.
Mutation of a non-conserved surface residue (M610R) led to a second
crystal form showing a substantially different conformation. Thus, the FN3
domain linker is highly flexible, suggesting that it corresponds to the hinge
seen in electron micrographs of NCAM. The two putative FGFR1-binding
segments, one in each NCAM FN3 domain, are situated close to the domain
interface. They form a contiguous patch in the more severely bent confor-
mation but become separated upon straightening of the FN3 tandem,
suggesting that conformational changes within NCAM may modulate
FGFR1 activation. Surface plasmon resonance experiments demonstrated
only a very weak interaction between the NCAM FN3 tandem and soluble
FGFR1 proteins expressed in mammalian cells (dissociation constant
N100 μM). Thus, the NCAM–FGFR1 interaction at the cell surface is likely
to depend upon avidity effects due to receptor clustering.© 2008 Elsevier Ltd.Open access under CC BY license.Keywords: cell adhesion; domain linker; crystal packing; protein interaction;
X-ray crystallographyEdited by I. WilsonIntroduction
The neural cell adhesion molecule (NCAM) is the
prototype and founding member of the immuno-
globulin (Ig) superfamily cell adhesion molecules
(CAMs).1–4 NCAM is present on the cell surface of
neurons, astrocytes and oligodendrocytes, where
it mediates homophilic and heterophilic cell adhe-
sion. NCAM is involved in neuronal migration,
axon growth and guidance, as well as in synaptic
plasticity associated with learning and memory.5–7
Alternative splicing of the NCAM1 gene results iness:
hesion molecule;
le; Ig,
ype 3; FGFR,
R, surface plasmon
, phosphate-buffered
ss under CC BY license.isoforms of three size classes that differ in their
membrane attachment and cytosolic regions but
have in common an extracellular domain consisting
of five Igs and two fibronectin type 3 (FN3)
domains.8 The two larger isoforms have a trans-
membrane helix and cytosolic domains of different
sizes, while the smallest isoform has a glycopho-
sphatidylinositol membrane anchor. Variable use of
alternative exons in the extracellular domain results
in small insertions into Ig4 or between the FN3
domains.9–12 NCAM function is further regulated by
an unusual posttranslational modification, namely,
the addition of polysialic acid to Ig5.13
The molecular basis of homophilic adhesion by
NCAM has been a subject of intense study, and the
results from biochemical and biophysical studies
have not always been consistent.14,15 A crystal struc-
ture of NCAM Ig1–Ig3 has led to a zipper model of
adhesion, which postulates both cis and trans
interactions by the Ig1–Ig3 region of NCAM.16
While a conclusive picture has yet to emerge, it
appears that there may be multiple modes of homo-
philic interaction.17
525Structure of the FN3 Domains of NCAMNCAM is also engaged in heterophilic interac-
tions. There is now convincing evidence that NCAM-
mediated neurite outgrowth, as well as tumour
development and progression, critically involves
the activation of fibroblast growth factor receptor 1
(FGFR1), through a cis interaction of NCAM and
FGFR1.18–22 The four FGFRs and their 23 growth
factor ligands control a variety of cellular processes,
including development, angiogenesis, hematopoi-
esis and tumourigenesis.23–26 Alternative splicing of
the four FGFR genes results in at least 48 receptor
isoforms that vary in their ligand binding profiles
and kinase domains. The longest FGFR1 ectodomain
variant consists of three Ig domains, D1–D3, with a
stretch of acidic amino acids (the “acid box”) inserted
into the D1–D2 linker; shorter forms lack D1 and
the acid box. The NCAM–FGFR1 interaction was
originally proposed based on indirect biological
evidence,27 but biochemical evidence has been
obtained to suggest that the interaction is mediated
by direct binding of the FN3 domains of NCAM to
FGFRs (Fig. 1).20,28,29 We and others identified
NCAM-derived peptides capable of stimulating
FGFR1 signalling and inducing neurite outgrowth.
One peptide (FRM peptide) is derived from the first
FN3 domain of NCAM (1FN3),30 while another (FGL
peptide) is derived from the second FN3 domain
(2FN3).28 The structures of the 1FN3 and 2FN3
domains in isolation have been determined,28,31 but
how the two domains cooperate in FGFR1 activation
is unclear. In this study, we determined the crystalFig. 1. Schematic drawing of NCAM and FGFR at the
cell surface. The cell membrane is represented by a thick
horizontal line. Ig and FN3 domains are represented by
ovals and rectangles, respectively. The cytosolic tyrosine
kinase domain of FGFR is represented by a hexagon; the
acid box (AB; see the text) is represented by a filled black
rectangle. The arrow indicates the interaction of two
NCAM regions (FRM and FGL; see the text) with FGFR.structure of the NCAM FN3 tandem (1FN3–2FN3)
in two crystal forms. We report that 1FN3–2FN3
assumes a bent conformation in both forms, with
evidence of substantial flexibility of the domain
linker. In direct binding experiments with fully
glycosylated proteins of mammalian origin, we
observed only a very weak interaction (dissociation
constant N100 μM) of NCAM 1FN3–2FN3 with two
FGFR1 ectodomain constructs. We conclude that
the NCAM–FGFR1 interaction at the cell surface
may be transient or stabilised by avidity effects re-
sulting from receptor clustering and that conforma-
tional changes within NCAM may have a profound
role in FGFR1 activation.Results
Crystal structure of the NCAM FN3 tandem
To obtain insight into the relative orientation of
the two FN3 domains of NCAM, we determined the
crystal structure of 1FN3–2FN3 at 2.3-Å resolution
(Table 1). Both 1FN3 and 2FN3 adopt the typical β-
sandwich fold of all FN3 domains consisting of
seven strands arranged in two antiparallel sheets
(ABE and GFCD) (Fig. 2a and b). Preceding strand A
in both domains are short proline-rich segments that
are integrated into the FN3 fold, with the proline
tetrahydropyrrole rings pointing into the hydro-
phobic core (Pro500 and Pro503 in 1FN3; Pro601 and
Pro604 in 2FN3). A similar feature has been ob-
served in other FN3 domains (e.g., in gp13033 and
titin34). 1FN3 contains an unusual α-helix situated
between strands D and E, as reported previously.31
1FN3 in our FN3 tandem structure matches the
crystal structure of 1FN3 in isolation,31 with an
r.m.s.d. of 0.50 Å for 100 Cα atoms. 2FN3 in our FN3
tandem matches the solution structure of 2FN3 in
isolation,28 with an r.m.s.d. of 1.3 Å for 92 Cα atoms
(the main differences are concentrated in the B–C
and C–D loops).
The relative orientation of the two FN3 domains
in the 1FN3–2FN3 tandem is characterised by an
unusually bent conformation with an interdomain
angle of ∼80° (calculated between the long axes of
the two FN3 domains). The interface between 1FN3
and 2FN3 buries 630 Å2 of solvent-accessible surface
(calculated with the CCP4 program AREAIMOL),
which is in the typical range for rigid FN3 (and Ig)
domain interfaces. The interface is dominated by
polar interactions, between the A–B loop of 1FN3 on
the one hand and the domain linker and B–C loop of
2FN3 on the other (Fig. 2c) The key interface residues
(Tyr511, Ser513, Thr514, Pro601 and Asp625) are
strictly conserved in all vertebrate NCAM sequences
(Fig. 2d), suggesting that the bent conformation
may be physiologically relevant. However, residues
511–514 have also been implicated in FGFR1
binding,30 and the linker region could assume a
very different structure when NCAM is bound to
FGFR1 (see below).
Table 1. Crystallographic statistics
Wild type KI-soaked wild type M610R mutant
Space group P212121 P212121 P212121
Unit cell dimensions (Å) a=52.77 a=51.43 a=92.42
b=71.35 b=73.00 b=107.57
c=98.21 c=97.31 c=161.12
Beamline SRS 14.1 European Synchrotron
Radiation Facility ID29
SRS 10.1
Wavelength (Å) 1.49 1.50 1.12
Resolution (Å) 20–2.3 (2.42–2.30)a 20–2.1 (2.21–2.10) 20–2.7 (2.85–2.70)
Unique reflections 16,957 22,059 44,403
Multiplicity 4.8 (4.8) 14.8 (15.0) 6.2 (5.6)
Completeness (%) 99.5 (100) 99.9 (100) 99.0 (97.2)
Rmerge 0.057 (0.118) 0.098 (0.342) 0.082 (0.448)
Average I/σ(I) 19.7 (11.1) 25.1 (7.9) 17.9 (4.3)
Heavy atom sites 20
Anomalous phasing power 1.6
Figure of merit 0.40
Protein atoms 3,058 9,264
Solvent sites 4 SO4
2−, 98 H2O 11 SO4
2−, 32 H2O
Rcryst/Rfree 0.218/0.272 0.223/0.268
Average B-factor of protein atoms (Å2) 22.8 40.8
Average B-factor of solvent atoms (Å2) 27.2 57.5
r.m.s.d. bonds (Å) 0.006 0.007
r.m.s.d. angles (°) 1.4 1.4
r.m.s. difference B-factors (Å2)b 1.9 1.7
Ramachandran plot (%)c 89.8/10.2/0/0 88.3/11.1/0.4/0.2
a Values in parentheses refer to the highest-resolution shell.
b r.m.s. difference between B-factors of atoms connected by a covalent bond.
c Percentage of residues in most favoured, additionally allowed, generously allowed and disallowed regions.32
526 Structure of the FN3 Domains of NCAMThe conformation of multidomain proteins often
is influenced by the crystal lattice. In this regard,
we noted that the asymmetric unit of our crystals
contains two 1FN3–2FN3 molecules arranged in a
tightly interlocked dimer (Fig. 2b). There are two
main contacts responsible for dimer formation: the
α-helix of 1FN3 packs against the GFCD sheet of
2FN3 of the other molecule, and the 2FN3 domains
of the two molecules interact via their A and G
strands. Altogether, these contacts bury as much as
3040Å2 of solvent-accessible surface. We do not
think that the dimer observed in our crystals is
physiologically relevant, as dimer interface residues
are only poorly conserved (Fig. 2d) and NCAM
dimers were never observed in electron microscopy
studies.35,36 Because we were concerned that the
tight association of 1FN3–2FN3 molecules in the
dimer may have forced the unusually bent inter-
domain conformation, we sought to disrupt the
dimer by mutagenesis and crystallise a mutant
1FN3–2FN3 protein in a different crystal form.
Structure of the M610R mutant
We expressed three point mutants of NCAM
1FN3–2FN3 (M610R, Y672E and R690E), all of
which should be incompatible with the dimer struc-
ture seen in crystals of the wild-type protein. Impor-
tantly, all three mutations target surface residues
and are unlikely to have an effect on NCAM folding.
Whether the mutations are functionally neutral
could not be determined due to a lack of suitable
assays. When examined by size-exclusion chromato-
graphy, all three mutants eluted as a mixture ofmonomers and dimers, similar to the wild-type
protein (data not shown).We obtained crystals of the
M610R mutant and determined its structure at 2.7-Å
resolution by molecular replacement (Fig. 3a). The
asymmetric unit of the crystals contains a hexamer
of NCAM 1FN3–2FN3 M610R. The hexamer can be
regarded as a trimer of dimers, with the dimers
having a completely different mode of association
compared with the wild-type structure (the indivi-
dual domains are very similar, as expected, with
r.m.s.d. values of 0.93 and 1.1 Å for 1FN3 and 2FN3,
respectively). The relative orientation of the two FN3
domains in the M610R mutant is less severely bent
than in the wild-type structure but still far from fully
extended (interdomain angle ∼120°; Fig. 3b). The
FN3 pair opens up in theM610Rmutant, and 1FN3 is
additionally twisted about its long axis. The com-
bined hinge opening and 1FN3 twisting amounts to a
pure rotation of 73° for 1FN3 when the structures are
superimposed on their 2FN3 domains. There is no
domain interface to speak of in the mutant (240 Å2
buried), and the conformation appears to be stabi-
lised entirely by the crystal lattice. Thus, crystal
lattice forces can have a profound influence on the
conformation of theNCAMFN3 tandem, suggesting
that the 1FN3–2FN3 linker may act as a flexible hinge
in native NCAM.
We compared the NCAM FN3 tandem with
other FN3 tandems of known structure. Tandems
from the extracellular matrix proteins fibronectin
and tenascin generally assume an extended con-
formation.38–40 In contrast, many cytokine and
hormone receptors (e.g., gp130)33 feature bent FN3
pairs that are superficially similar to the NCAM
Fig. 2. Structure of the NCAM FN3 tandem. (a) Cartoon drawing of the wild-type 1FN3–2FN3 structure. Two loops
implicated in FGFR1 binding (see the text) are labelled. (b) Cartoon drawing of the 1FN3–2FN3 dimer viewed along the 2-
fold non-crystallographic symmetry axis. The 1FN3 and 2FN3 domains are shown in yellow and brown, respectively. The
side chain of M610 in the dimer interface (see the text) is shown as a ball-and-stick model and is labelled. (c) Close-up view
of the domain interface in wild-type 1FN3–2FN3: 1FN3 is shown in yellow; 2FN3, in brown. Selected residues are shown as
ball-and-stick models. Hydrogen bonds are indicated by dashed lines. (d) Sequence alignment of the FN3 tandem of
selected vertebrate NCAMs. Conserved residues are shaded pink. The numbering scheme and secondary structure
elements of human NCAM are indicated above the alignment. The alternative splice inserts in the 1FN3–2FN3 linker (see
the text) are indicated by black boxing. Two sequences implicated in FGFR1 binding (see the text) are underlined in blue.
Residues involved in forming the dimer shown in (b) are indicated by filled circles, with the number of circles being
proportional to the accessible surface area buried in the dimer: red circles indicate dimer contact between the α-helix of
1FN3 and the GFCD sheet of 2FN3; cyan circles, dimer contact between β-strands A and G of 2FN3.
527Structure of the FN3 Domains of NCAMstructures reported here (data not shown). Of
particular interest is the structure of the FN3 pair
of neuroglian, a Drosophila CAM.37 The neuroglian
tandem, which has an extensive domain interface
that incorporates a bound sodium ion, adopts a
conformation that is intermediate between the two
conformations we report for the NCAM tandem.
Thus, a similar bend in the FN3 linker(s) may be a
general feature of other animal CAMs containing
FN3 domains in their membrane-proximal region.Location of putative FGFR1 binding site
Previous studies have implicated two NCAM
1FN3–2FN3 regions in FGFR1 binding. Kiselyov
et al. identified a bioactive peptide from the F–G
loop of 2FN3 (FGL peptide),28 and we identified a
bioactive peptide from the A–B loop of 1FN3 (FRM
peptide).30 In agreement with our earlier pre-
diction,30 the FRM and FGL loops are indeed located
in close proximity on the same face of the wild-type
Fig. 3. Structure of M610R mutant. (a) Cα trace of the structure of the NCAM 1FN3–2FN3 M610R mutant, viewed
along the 3-fold non-crystallographic symmetry axis. One molecule is highlighted in yellow (1FN3 domain) and brown
(2FN3 domains). (b) Superposition of the FN3 pairs of wild-type NCAM (cyan), NCAM M610R mutant (green) and
neuroglian (magenta).37 The structures were superimposed on the conserved β-strands of the second FN3 domain. wt
indicates wild type.
528 Structure of the FN3 Domains of NCAMNCAM molecule (Fig. 4a). However, in the M610R
mutant, the opening up of the two domains com-
bined with rotation of 1FN3 places the FRM and
FGL loops much farther apart. Thus, conformational
changes at the NCAM 1FN3–2FN3 hinge may
modulate the interaction of NCAM with FGFR1.
Surface plasmon resonance analysis of the
NCAM–FGFR1 interaction
We wanted to map the FGFR1 binding site on the
NCAM FN3 tandem by structure-based mutagen-
esis and first sought to establish a suitable binding
assay. A solid-phase assay with immobilised NCAM
and Fc-tagged FGFR1 proteins did not show any
appreciable interaction (data not shown). We there-Fig. 4. Location of putative FGFR1 binding site. Shown are s
and (b) its M610R mutant. The FRM and FGL sequences (seefore used surface plasmon resonance (SPR) to
analyse the binding of NCAM 1FN3–2FN3 to two
FGFR1 ectodomain constructs. The FGFR1 D1–D3
construct used (residues 22–364) spans essentially
the full ectodomain and contains the acid box
situated between domains D1 and D2. The FGFR1
D2–D3 construct used (residues 151–364) lacks D1
and the acid box but retains the binding site for
FGFs; this construct is similar to the construct
previously used by Kiselyov et al. in SPR studies.28
Both soluble FGFR1 proteins were produced by the
293-EBNA cells in good yields. Due to the presence
of multiple N-linked glycosylation sites in FGFR1
(see below), the purified recombinant proteins
migrate as diffuse bands of higher-than-calculated
molecular mass on SDS-PAGE (Fig. 5). In a first set ofurface representations of (a) wild-type NCAM 1FN3–2FN3
the text) are shown in red and yellow, respectively.
Fig. 5. SDS-PAGE analysis of recombinant NCAM and
FGFR1 proteins. Coomassie blue-stained gel of His-tagged
soluble proteins expressed in 293-EBNA cells. The posi-
tions of molecular mass standards (in kilodaltons) are
indicated on the left. The FGFR1 proteins are modified by
extensive glycosylation; the NCAM proteins are not
glycosylated.
†www.cbs.dtu.dk/services/NetOGlyc
529Structure of the FN3 Domains of NCAMexperiments, the two FGFR1 constructs were immo-
bilised on a CM5 sensor chip [8000 resonance units
(RU) of D1–D3 and 3850 RU of D2–D3]. Recombi-
nant FGF1 injected at a concentration of 100 nM
produced sensorgrams characteristic of a high-
affinity interaction, confirming that the immobilised
proteins are functional (Fig. 6a and b). In contrast,
wild-type NCAM 1FN3–2FN3 up to a concentration
of 70 μM did not produce a signal on the FGFR1
D1–D3 surface and showed only very weak binding
to FGFR D2–D3 (Fig. 6c and d). In a second set of
experiments, the order of proteins was reversed.
NCAM 1FN3–2FN3 proteins were immobilised on a
CM4 sensor chip (1800 RU of wild-type protein and
1900 RU of M610R mutant), and the two soluble
FGFR1 constructs were used as analytes up to a
concentration of 100 μM. We again observed only
weak interactions for all pairings (Fig. 6e–h). Wild-
type and M610R NCAM 1FN3–2FN3 behaved
almost identically in these experiments, and, as
before, it appeared that the affinity of NCAM for
FGFR1 D2–D3 was higher than that for FGFR1 D1–
D3. The fast association and dissociation steps in the
sensorgrams prevented the fitting of kinetic con-
stants. We used the plateau values at equilibrium to
estimate a dissociation constant of N100 μM for the
interaction of NCAM 1FN3–2FN3 with FGFR1 D2–
D3 (not shown), but we emphasise that this value is
very approximate given the weak resonance signals
obtained. In view of the weakness of the NCAM–
FGFR1 interaction in our assay, we were unable
to pursue our initial plans of mapping the binding
site(s) by mutagenesis.Discussion
NCAM ectodomain structure
The current view of the NCAM ectodomain struc-
ture is based on early studies by rotary shadowing
electron microscopy of tissue-derived NCAM.35
Electron microscopy visualised the NCAM ectodo-
main as ∼28-nm rods bent at a flexible hinge located
∼10 nm from the C-terminus; the angle between the
two arms varied from 50° to 140° (average=100°).
The hinge was attributed to the proline-rich linker
between Ig5 and the first FN3 domain, and the long
and short arms were described as rigid domain
tandems (Ig1–Ig5 and 1FN3–2FN3, respectively) in
extended conformations.35 A crystal structure of
NCAM Ig1–Ig3 indeed showed a largely extended
structure.16 In sharp contrast, the present crystal
structure analysis of the NCAM 1FN3–2FN3 domain
pair has revealed a prominent bend between the
two domains in two independent crystal forms
(Fig. 3b). This finding is difficult to reconcile with the
uniformly straight appearance of the short arm in
the electron micrographs and suggests that the
hinge point may actually lie between 1FN3 and
2FN3. In this respect, we note that the Ig5–1FN3
linker is actually rather short and may well be rigid
(in the Ig5–1FN3 linker sequence, ILVQADTPSSP,
the isoleucine and valine residues are predicted to
contribute to the hydrophobic core of Ig5 and the
first proline is already part of the 1FN3 fold). If the
hinge is instead situated in the 1FN3–2FN3 linker,
the juxtamembrane domain of NCAM must have
contributed to the short arm seen in electron micro-
graphs, as a single FN3 domain would only account
for half of the short arm length. The serine/
threonine-rich juxtamembrane domain of NCAM
(sequence TSAQPTAIPANGSPTSGLSTGA) is pre-
dicted to be extensively modified by O-linked gly-
cosylation (NetOGlyc 3.1 server†) and could easily
assume the extended and rigid conformation
required to span the remaining ∼5 nm.41 Further
structural analysis, in particular, of the Ig5–1FN3
pair, is required to conclusively pinpoint the site of
articulation within the NCAM ectodomain.
NCAM splice variants
Interestingly, the flexible hinge linking the two
FN3 domains of NCAM 1FN3–2FN3 is known to
be modified by alternative splicing. Our structure
is of the shortest isoform (linker sequence
TQPVREPSAP), whereas the underlined arginine
residue is replaced by QG, HSPPPQG or even
longer sequences in other variants.9,10,12 The
HSPPPQG insertion has been suggested as a
potential hinge region.1 The biological relevance
of these splicing events is not well understood, but
in vitro experiments have demonstrated that the
Fig. 6. SPR analysis of the NCAM–FGFR1 interaction. Shown are raw sensorgrams obtained on a Biacore 3000
instrument. Selected curves are labelled with the respective analyte concentration. (a) Binding of 0.1 μM FGF1 to
immobilised FGFR1 D1–D3. (b) Binding of 0.1 μMFGF1 to immobilised FGFR1 D2–D3. (c) Binding of 4.4, 8.8, 17.5, 35 and
70 μMNCAM 1FN3–2FN3 to immobilised FGFR1 D1–D3. (d) Binding of 4.4, 8.8, 17.5, 35 and 70 μMNCAM 1FN3–2FN3 to
immobilised FGFR1 D2–D3. (e) Binding of 1, 3, 10, 30 and 100 μM FGFR1 D1–D3 to immobilised wild-type NCAM
1FN3–2FN3. (f) Binding of 1, 3, 10, 30 and 100 μM FGFR1 D2–D3 to immobilised wild-type NCAM 1FN3–2FN3. (g)
Binding of 1, 3, 10, 30 and 100 μMFGFR1 D1–D3 to immobilised NCAM 1FN3–2FN3M610R. (h) Binding of 1, 3, 10, 30 and
100 μM FGFR1 D2–D3 to immobilised NCAM 1FN3–2FN3 M610R.
530 Structure of the FN3 Domains of NCAMNCAM isoforms differ in their capacity to support
cell adhesion and spreading,42,43 as well as myoblast
fusion.44 We prepared NCAM 1FN3–2FN3 proteins
with QG or HSPPPQG inserts in the domain linker,
but, unfortunately, these proteins were very prone
to aggregation in physiological buffers and could
not be used for SPR or structural analysis (data
not shown).Interaction of NCAM with FGF
Hinge bending and alternative splicing at the
1FN3–2FN3 junction could affect NCAM function
by modulating either its homophilic binding proper-
ties or its heterophilic interactions with other pro-
teins. There is currently no evidence for the former
scenario. In contrast, the functional interaction of
531Structure of the FN3 Domains of NCAMNCAMwith FGFR1 in cis (i.e., at the same cell mem-
brane) is well established1,22,30 and would appear to
be an attractive candidate for regulation by alter-
native splicing. Peptides from two regions of the
NCAM 1FN3–2FN3 tandem, one in each domain,
have been shown to modulate FGFR1-dependent
neurite outgrowth.28,30 Intriguingly, the correspond-
ing loop regions are in close proximity in the acutely
bent conformation observed in crystals of the wild-
type protein, suggesting that they are part of a larger
FGFR1 binding site extending over the domain
junction. In crystals of the M610R mutant, the two
putative FGFR1-binding loops are farther apart
and no longer on the same face of the 1FN3–2FN3
structure (Fig. 4). Thus, changes in the 1FN3–2FN3
conformation, either by biomechanical forces result-
ing from cell–cell contact or by alternative splicing,
could have a profound effect on the NCAM–FGFR1
interaction. Other NCAM activities that might be
affected by alternative splicing of the 1FN3–2FN3
linker include interactions with polysialyltrans-
ferases31 and prion protein,45 which both bind to
the FN3 domains.
Previous biochemical studies reported a dissocia-
tion constant of ∼10 μM for the interaction between
NCAM 1FN3–2FN3 and FGFR1 D2–D3.28,29 Another
study, using cell-based assays, concluded that the
acid box in the FGFR1D1–D2 linker was essential for
the NCAM–FGFR1 interaction.20 We wanted to use
SPR binding experiments to identify NCAM resi-
dues involved in FGFR1 binding and test the effect
of splice inserts in the 1FN3–2FN3 linker. Unfortu-
nately, using our recombinant proteins expressed in
mammalian cells (Fig. 5), we were unable to detect
substantial binding between soluble FGFR1 and
NCAM proteins, regardless of whether FGFR1 or
NCAM was immobilised on the sensor chip. A very
weak interaction (estimated dissociation constant
N100 μM) was evident between FGFR1 D2–D3 and
NCAM 1FN3–2FN3, but we observed no NCAM
binding to the FGFR1 D1–D3 construct containing
the acid box (Fig. 6). The most likely explanation for
the discrepancy between our findings and those of
Christensen et al.29 is the difference in glycosylation
of the FGFR1 proteins used. Christensen et al.
expressed FGFR1 D2–D3 in insect cells, which
produce N-linked oligosaccharides of the high-
mannose type, whereas our expression system
(human embryonic kidney cells) produces com-
plex-type oligosaccharides, which more closely
resemble the glycan present on mammalian FGFRs.
Human and rodent FGFR1 proteins are highly glyco-
sylated, and the glycan is known to influence ligand
binding.46 We think that there may be electrostatic
repulsion between the acidic NCAM 1FN3–2FN3
protein (isoelectric point 5.0) and the terminal sialic
acids present on FGFR1 expressed in human cells.
The very weak interaction we observed between
soluble NCAM and FGFR1 proteins does not
preclude a critical role of this interaction at the cell
surface, where avidity effects due to receptor clus-
teringmay be substantial. An attractive hypothesis is
that the functional state of NCAM (i.e., whether it isengaged in a homophilic contact or not) is linked
to FGFR1 binding and activation. It is tempting
to speculate that the flexible 1FN3–2FN3 linkage
revealed by our structural analysis could provide the
molecular means for such a regulatory mechanism.Experimental Procedures
Expression vectors
NCAM constructs were made by PCR amplification
from a bacterial expression vector coding for the FN3 pair
of human NCAM. Our NCAM numbering scheme
corresponds to SwissProt entry P13591 up to residue
598 but differs by −1 from P13591 for all subsequent resi-
dues due to the replacement of Gln599–Gly600 by Arg,
a naturally occurring splice variant in the brain and
muscle.12 The M610R mutation in NCAM was introduced
by strand-overlap-extension PCR. FGFR1 constructs were
made by PCR amplification from a complete cDNA clone
of human FGFR1 (IIIc isoform; our numbering scheme
corresponds to SwissProt entry P11362). The PCR pro-
ducts were cloned into a modified pCEP-Pu vector47
coding for proteins with a C-terminal His6 tag. The insert
sequences of all expression vectors were verified by DNA
sequencing. The domain boundaries of the constructs are
as follows: NCAM 1FN3–2FN3, QADTP…VFRTS (496–
692); FGFR1 D1–D3, RPSPT…EALEE (22–364); and FGFR1
D2–D3, VAPYW…EALEE (151–364). Vector-derived APLA
and AAAHHHHHH sequences are additionally present at
the N- and C-terminus, respectively.
Protein expression and purification
All proteins were purified from the conditioned
medium of episomally transfected 293-EBNA cells. Cells
were cultured in Dulbecco's modified Eagle's medium
supplemented with 10% fetal calf serum (Invitrogen),
transfected using Fugene reagent (Roche Applied Science)
and selected with 1 μg/ml of puromycin (Sigma). Proteins
were purified by a combination of affinity and size-
exclusion chromatography performed on an Äkta plat-
form (GE Healthcare). Typically, 1.5 l of conditioned
serum-free medium was loaded onto a 5-ml HisTrap
column (GE Healthcare) equilibrated in phosphate-buf-
fered saline (PBS) buffer, pH 7.45 (140 mM NaCl, 10 mM
Na2PO4 and 3 mM KCl), and eluted with 500 mM
imidazole in PBS. The eluate was concentrated using
Vivaspin centrifugal devices (Sartorius AG) and further
purified on a 24-ml Superdex 200 size-exclusion chroma-
tography column (GE Healthcare) with Tris-buffered
saline (TBS) buffer, pH 7.4, as the running buffer. Purified
proteins were analysed by SDS-PAGE, quantified by
measuring their absorption at 280 nm, concentrated to
the final desired concentrations and flash-frozen in liquid
nitrogen for storage at −80 °C. Final yields were 10–20 mg
of pure protein per litre of cell culture medium.Crystallisation and structure determination
NCAM 1FN3–2FN3 was concentrated to 13 mg/ml in
TBS, and crystals were obtained by hanging drop vapour
diffusion at room temperature using 2.2 M ammonium
sulfate, 0.1 M sodium citrate, pH 5.2, 0.2 M potassium/
sodium tartrate and 3–5% ethanol as precipitant. Crystals
532 Structure of the FN3 Domains of NCAMgrew within 2 days and belong to space group P212121
with unit cell dimensions a=52.77 Å, b=71.35 Å and
c=98.22 Å. There are two 1FN3–2FN3 molecules in the
asymmetric unit, resulting in a solvent content of ∼38%.
Crystals were flash-frozen in liquid nitrogen after brief
soaking in mother liquor supplemented with 20% gly-
cerol. A crystal was soaked in mother liquor supplemen-
ted with 300 mM potassium iodide for 30 s before freezing
to obtain a heavy atom derivative. Diffraction data from
native and KI derivative crystals were collected at 100 K
on station 14.1 at the Synchrotron Radiation Source (SRS)
Daresbury and on station ID29 at the European Synchro-
tron Radiation Facility Grenoble, respectively. The NCAM
1FN3–2FN3M610Rmutant was concentrated to 14 mg/ml
in TBS, and crystals were obtained by sitting drop vapour
diffusion at room temperature using 2 M ammonium
sulfate and 0.1 M sodium acetate, pH 4.6, as precipitant.
Crystals grew within 3–4 days and belong to space group
P212121 with unit cell dimensions a=92.74 Å, b=107.49 Å
and c=161.18 Å. There are six copies of mutant
1FN3–2FN3 in the asymmetric unit, resulting in a solvent
content of ∼42%. Crystals were flash-frozen in liquid
nitrogen after brief soaking in mother liquor supplemen-
ted with 20% glycerol, and diffraction data were collected
at 100 K on station 10.1 at the SRS Daresbury. The
diffraction data were processed with MOSFLM‡ and
programs of the CCP4 suite.48 The structure of NCAM
1FN3–2FN3 was solved by single-wavelength anomalous
dispersion phasing of a KI-soaked crystal using SHARP
(Globalphasing Ltd., Cambridge) in full automatic mode.
The structure was rebuilt with O49 and refined with
Crystallography & NMR System.50 The structure of the
NCAMM610Rmutant was solved with some difficulty by
molecular replacement with PHASER,51,52 using the
isolated FN3 domains of the NCAM 1FN3–2FN3 structure
as search models. Data collection, phasing and refinement
statistics are summarised in Table 1. The figures were
made with PyMOL§.
SPR experiments
Binding experiments were performed on a Biacore 3000
instrument (GE Healthcare) at 25 °C. Proteins were
immobilised on activated CM4 or CM5 chips using
standard amine coupling procedures following the manu-
facturer's instructions. Briefly, flow cells were activated
with 20 μl of a mixture of 0.2 M 1-ethyl-3-(3-dimethy-
laminopropyl)carbodiimide and 0.05 M N-hydroxy-sul-
fosuccinimide at a flow rate of 5 μl/min. The proteins
to be immobilised (50–100 μg/ml in 10 mM sodium
acetate, pH 4.5–5.5) were allowed to pass over activated
flow cells to reach ∼2000–8000 RU, after which un-
reacted groups were blocked with 20 μl of 1 M
ethanolamine, pH 8.5. Reference flow cells without
protein were treated identically. The chips were equili-
brated in 10 mM Hepes, pH 7.4, 150 mM NaCl, 50 μM
ethylenediaminetetraacetic acid and 0.005% surfactant
P20 (HBS-EP buffer), and serial dilutions of analyte pro-
teins in PBS (our recombinant proteins or FGF1 from
PeproTech) were injected at 20 μl/min for 300 s, followed
by 200 s of pure buffer to monitor dissociation. Chips
were regenerated using HBS-EP with 1 M glycine–HCl,
pH 3.5. The sensorgrams were analysed with the BiaEva-
luation 4.1 software.‡www.mrc-lmb.cam.ac.uk/harry/mosflm
§www.pymol.orgProtein Data Bank accession codes
Coordinates and structure factors for wild-type and
M610R NCAM 1FN3–2FN3 have been deposited in the
ProteinData Bankwith codes 2vkwand 2vkx, respectively.Acknowledgements
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